@return2ozma to News • 8 months agoOzempic maker Novo Nordisk facing pressure as study finds $1,000 appetite suppressant can be made for just $5fortune.comexternal-linkmessage-square158arrow-up1618arrow-down117cross-posted to: [email protected][email protected][email protected][email protected]health
arrow-up1601arrow-down1external-linkOzempic maker Novo Nordisk facing pressure as study finds $1,000 appetite suppressant can be made for just $5fortune.com@return2ozma to News • 8 months agomessage-square158cross-posted to: [email protected][email protected][email protected][email protected]health
minus-square@Marcbmannlink2•edit-28 months agoNovo Nordisk’s CEO was paid $9.8 million last year, inclusive of bonus and benefits.
Novo Nordisk’s CEO was paid $9.8 million last year, inclusive of bonus and benefits.